Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig.1.D
Wang H et al. (2021)
|
Xla Wt + fermt2 MO
NF15 (in situ hybridization)
|
|
|
|
Fig.3.H,I
Wang H et al. (2021)
|
Xla Wt + fermt2 MO
NF15 (in situ hybridization)
|
|
|
|
Fig.5.D-H
Wang H et al. (2021)
|
Xla Wt + fermt2 MO
NF15 (in situ hybridization)
|
|
|
|
Fig.5.D-F
Wang H et al. (2021)
|
Xla Wt + fermt2 MO
NF15 (in situ hybridization)
|
|
|
|
Fig.3.B
Wang H et al. (2021)
|
Xla Wt + wnt3a + chd1 + animal cap explant
NF15 (RT-PCR)
|
|
|
|
Fig.4.A
Perfetto M et al. (2021)
|
Xtr Wt + AKTi
NF12.5 (in situ hybridization)
|
|
|
|
Fig.S.2
Perfetto M et al. (2021)
|
Xtr Wt + ddx3x
NF12.5 (in situ hybridization)
|
|
|
|
Fig.1.B-C
Perfetto M et al. (2021)
|
Xtr Wt + ddx3x MO
NF12.5 (in situ hybridization)
|
|
|
|
Fig.5.A
Perfetto M et al. (2021)
|
Xtr Wt + ddx3x MO
NF12.5 (in situ hybridization)
|
|
|
|
Fig. 6 B C
Farley-Barnes KI et al. (2020)
|
Xtr + pax9 MO
NF18-19 (in situ hybridization)
|
|
|